The EPIC Study: Exploring Paternal Age and the Influence on Blastocyst Culture

Recruiting N/A Interventional Study
Infertility (IVF Patients) Oocyte Competence Sperm DNA Fragmentation Paternal Age Sperm Selection
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 41
Sex
Female
Study type
Interventional
Purpose
Other
Participants needed
100 (estimated)
Sponsor
Reproductive Medicine Associates of New Jersey · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study aims to assess the effect of age of the male partner and the reproductive ability of sperm prepared via sperm selection devices (Zymot) compared to routine embryologist selected sperm after density gradient centrifugation (DGC) preparation for intracytoplasmic sperm injection (ICSI) in patients undergoing in vitro fertilization treatment (IVF) of their infertility.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Undergoing first IVF cycle * Electing single embryo transfer * Electing PGT-A of their embryos * Female partners age \<42 years old at start of VOR cycle, but \>18 years old. * AMH ≥ 1.2 ng/mL * AFC ≥ 8 * FSH ≤ 12IU/L * At least 4 mature oocytes (M2s) retrieved at the VOR proc…
Contacts

Caroline Clinical Research Nurse, BSN, RN

973-656-2841

clinicalresearchteam@ivirma.com

CONTACT

Christine Director of Research Operations, MS, BSN, RN

973-656-2841

clinicalresearchteam@ivirma.com

CONTACT